Deborah C. Molrine

3.0k total citations · 1 hit paper
34 papers, 2.1k citations indexed

About

Deborah C. Molrine is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Deborah C. Molrine has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Deborah C. Molrine's work include Clostridium difficile and Clostridium perfringens research (9 papers), Pneumonia and Respiratory Infections (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Deborah C. Molrine is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (9 papers), Pneumonia and Respiratory Infections (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Deborah C. Molrine collaborates with scholars based in United States, India and Australia. Deborah C. Molrine's co-authors include Donna M. Ambrosino, Israel Lowy, Brett Leav, Mark D. Leney, Barbra M. Blair, Roger Baxter, William D. Thomas, Dale N. Gerding, Susan Sloan and Geoffrey Nichol and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Deborah C. Molrine

34 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

2010 557 citations Israel Lowy, Deborah C. Molrine et al. New England Journal of Medicine profile →

Peers

Deborah C. Molrine

EPIDE

IMMUN

SURGE

HEPAT

Francesca Meacci Italy

Lena Grillner Sweden

Donna M. Ambrosino United States

Valeria Ghisetti Italy

Göran Bratt Sweden

Dimpy P. Shah United States

J Giron Spain

Marcie Tomblyn United States

G. Filice Italy

Setareh Mamishi Iran

Francesca Meacci Italy

Deborah C. Molrine

740 ×0.5

EPIDE

433 ×0.4

431 ×1.4

IMMUN

190 ×0.7

SURGE

82 ×0.4

HEPAT

Citations per year, relative to Deborah C. Molrine Deborah C. Molrine (= 1×) peers Francesca Meacci

Countries citing papers authored by Deborah C. Molrine

Since Specialization

Citations

This map shows the geographic impact of Deborah C. Molrine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah C. Molrine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah C. Molrine more than expected).

Fields of papers citing papers by Deborah C. Molrine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah C. Molrine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah C. Molrine. The network helps show where Deborah C. Molrine may publish in the future.

Co-authorship network of co-authors of Deborah C. Molrine

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah C. Molrine. A scholar is included among the top collaborators of Deborah C. Molrine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah C. Molrine. Deborah C. Molrine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lambert, Paul‐Henri, Donna M. Ambrosino, Svein Rune Andersen, et al.. (2020). Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 38(31). 4783–4791. 73 indexed citations

Gogtay, Nithya, Renuka Munshi, D H Ashwath Narayana, et al.. (2017). Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study. Clinical Infectious Diseases. 66(3). 387–395. 60 indexed citations

Gupta, Swati B., Vinay Mehta, Erik R. Dubberke, et al.. (2016). Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence. Clinical Infectious Diseases. 63(6). 730–734. 55 indexed citations

Smith, Heidi L., Raymond T. Chung, Parvez Mantry, et al.. (2016). Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Journal of Viral Hepatitis. 24(3). 197–206. 9 indexed citations

Babcock, Gregory J., Sowmya Iyer, Heidi L. Smith, et al.. (2014). High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody. PLoS ONE. 9(6). e100325–e100325. 18 indexed citations

Morin, Trevor J., Teresa J. Broering, Brett Leav, et al.. (2012). Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees. PLoS Pathogens. 8(8). e1002895–e1002895. 133 indexed citations

Lowy, Israel, Deborah C. Molrine, Brett Leav, et al.. (2010). Treatment with Monoclonal Antibodies against Clostridium difficile Toxins. New England Journal of Medicine. 362(3). 197–205. 557 indexed citations breakdown →

Leav, Brett, Barbra M. Blair, Mark D. Leney, et al.. (2009). Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine. 28(4). 965–969. 193 indexed citations

Tummala, Sanjeev, Deborah C. Molrine, Lisa Davidson, et al.. (2008). Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine. 26(27-28). 3404–3409. 43 indexed citations

10.

Molrine, Deborah C.. (2007). Safety and Pharmacokinetics of Human Monoclonal Antibodies to Clostridium difficile Toxin A and Toxin B in Healthy Adults. 1 indexed citations

11.

Antin, Joseph H., Eva C. Guinan, David Avigan, et al.. (2005). Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 11(3). 213–222. 40 indexed citations

12.

Molrine, Deborah C.. (2003). Recommendations for immunizations in stem cell transplantation. Pediatric Transplantation. 7(s3). 76–85. 4 indexed citations

13.

Vernacchio, Louis, Henry H. Bernstein, Stephen I. Pelton, et al.. (2002). Effect of monophosphoryl lipid A (MPL®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM197 conjugate vaccine in healthy toddlers. Vaccine. 20(31-32). 3658–3667. 40 indexed citations

14.

Molrine, Deborah C. & Patricia L. Hibberd. (2001). Vaccines for Transplant Recipients. Infectious Disease Clinics of North America. 15(1). 273–305. 40 indexed citations

15.

Vernacchio, Louis, Sandra Romero‐Steiner, Joseph Martinez, et al.. (2000). Comparison of an Opsonophagocytic Assay and IgG ELISA to Assess Responses to Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccines in Children and Young Adults with Sickle Cell Disease. The Journal of Infectious Diseases. 181(3). 1162–1166. 48 indexed citations

16.

Stack, Anne M., et al.. (2000). Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model. Vaccine. 18(14). 1412–1418. 25 indexed citations

17.

Molrine, Deborah C., et al.. (1999). Normal IgG and Impaired IgM Responses to Polysaccharide Vaccines in Asplenic Patients. The Journal of Infectious Diseases. 179(2). 513–517. 21 indexed citations

18.

Vernacchio, Louis, et al.. (1998). Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. The Journal of Pediatrics. 133(2). 275–278. 81 indexed citations

19.

Chan, Christina Y., Deborah C. Molrine, Suzanne George, et al.. (1996). Pneumococcal Conjugate Vaccine Primes for Antibody Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease. The Journal of Infectious Diseases. 173(1). 256–258. 94 indexed citations

20.

Guinan, Eva C., Deborah C. Molrine, Joseph H. Antin, et al.. (1994). POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1. Transplantation. 57(5). 677–684. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact